Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Liver Disease
100%
Metabolic Dysfunction-Associated Steatotic Liver Disease
85%
Liver Cirrhosis
72%
Fibrosis
71%
Metabolic Dysfunction-Associated Steatohepatitis
54%
Nonalcoholic Fatty Liver
49%
Systematic Review
43%
Macrophage
43%
Public Health
40%
Chronic Liver Disease
37%
Decompensated Liver Cirrhosis
35%
Hepatology
33%
Randomized Controlled Trial
32%
Clinical Trial
31%
Fatty Liver
30%
Maturity Onset Diabetes of the Young
29%
Prevalence
27%
Retrospective Study
26%
Diseases
25%
Morbidity
25%
Liver Fibrosis
21%
COVID-19
21%
Drug Therapy
19%
Hepatitis B
18%
Physical Activity
18%
Clinician
18%
Alcohol-Related Liver Disease
17%
Liver Function
17%
Patient Referral
16%
Nutrition
16%
Disease Management
16%
Model for End-Stage Liver Disease
15%
Hepatocellular Carcinoma
14%
Liver Transplantation
14%
Cell Therapy
13%
Diabetes
13%
Alcohol Consumption
13%
Primary Health Care
13%
Frailty
13%
Adverse Event
12%
Inflammation
12%
Cohort Studies
12%
Specialist Care
12%
Biological Marker
11%
Hepatitis C
10%
Cohort Analysis
10%
Chronic Kidney Disease
10%
Odontoid Process Fracture
10%
Neuro-Oncology
10%
Subdural Hematoma
10%
Keyphrases
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
75%
Liver Disease
55%
Non-alcoholic Fatty Liver Disease (NAFLD)
39%
Phosphoinositide 3-kinase (PI3K)
32%
Chronic Liver Disease
29%
Europe
25%
T Cells
24%
Type 2 Diabetes Mellitus (T2DM)
23%
Cirrhosis
22%
Scotland
22%
Metabolic Dysfunction-associated Steatohepatitis
21%
Decompensated Cirrhosis
21%
Hepatitis C
21%
Multicenter Retrospective Study
21%
Hepatitis B
21%
Co-management
21%
Macrophages
21%
Macrophage Therapy
21%
Fibrosis
21%
Epidemiology
19%
Interleukin-2
19%
Clinical Practice Guidelines
17%
Liver Cirrhosis
17%
Liver Disease Management
16%
Cell Therapy
16%
HBV Infection
16%
Public Health Risk
16%
Fibrosis Assessment
15%
Living with
14%
Advanced Liver Disease
14%
Narrative Review
14%
Liver
14%
Rapamycin
13%
Disease Diagnosis
13%
Phosphorylation
12%
Older Adults
11%
Care Delivery
11%
Hepatocellular Carcinoma
11%
S6 Kinase 1 (S6K1)
11%
Soluble interleukin-2 Receptor (sIL-2R)
11%
Chronic Infection
11%
Lifestyle Management
10%
Steatotic Liver Disease
10%
Management Guidelines
10%
Resmetirom
10%
Drug-induced Liver Injury
10%
Cervical Spine Fracture
10%
Aging Patients
10%
Population-based Study
10%
Acute Myocardial Infarction
10%